Evidence map›Paper›PMID 41117179›Full record

ReviewCurrent opinion in nephrology and hypertension2026

Peritoneal dialysis and heart failure.

Caroline M Hsu, Daniel E Weiner, Wendy McCallum

Abstract readReview
In one paragraph

Review in Current opinion in nephrology and hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Caroline M HsuDivision of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.
Daniel E Weiner
Wendy McCallum

Funding

Relation between acute changes in kidney function with clinical outcomes among patients with heart failureK23DK128657 · NIDDK · TUFTS MEDICAL CENTER · PI Wendy MCCALLUM · 2023 to 2026
$765k
NIDDK NIH HHS K23 DK128657
6 · The paper itself

Abstract

purpose of reviewHeart failure and chronic kidney disease are frequently comorbid, with both characterized by salt and water retention that lead to clinical deterioration. Peritoneal dialysis can effectively treat fluid overload and maintain euvolemia but remains underutilized. This review addresses the use of peritoneal dialysis in heart failure, including its potential advantages and also its challenges. RECENT

findingsThe 2019 Advancing American Kidney Health initiative incentivized increased use of peritoneal dialysis in the United States. There is, therefore, growing recognition of peritoneal dialysis's appropriateness for heart failure, in that it can effectively remove volume, often with greater hemodynamic stability than intermittent hemodialysis. Peritoneal dialysis additionally avoids the risk of systemic bloodstream infection, which may be particularly high risk for patients with cardiac devices. System and logistic challenges remain for more widespread uptake of peritoneal dialysis in people with kidney failure and heart failure, including limited ability to urgently start peritoneal dialysis and clinician and hospital inexperience. SUMMARY: Peritoneal dialysis is an effective therapy for heart failure in individuals with kidney failure but remains underutilized. Strategies for increased uptake include provider education and greater structural and logistic support, particularly in the inpatient setting.

Indexed as

Heart FailureKidney Failure, ChronicPeritoneal DialysisHemodynamicsHumansRisk FactorsTreatment Outcomeend-stage kidney diseasehealth systemsheart failurehome dialysisperitoneal dialysis

Identifiers

PMID41117179
PMCPMC12820935

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.